Vilazodone for Separation Anxiety Disorder in Adults

A research study offering cost-free research treatment for people who are suffering from adult separation anxiety disorder (ASAD), a new psychiatric condition.  The goal of this study is to establish effective treatments for ASAD, based on what is known about the causes of separation anxiety and about treatments known to help related conditions.  This study uses a computer game, questionnaires, and psychiatric interviews in order to determine any changes in symptoms due to research medication.  All information will be kept completely confidential.

Organization: 
Anxiety Disorders Clinic, New York State Psychiatric Institute/Columbia University Medical Center
Principal Investigator: 
Franklin Schneier, MD
Eligibility Criteria: 

•    Adult separation anxiety disorder (ASAD) is your primary problem
•    You are between the ages of 18 and 60
•    You are interested in receiving cost-free research treatment medication

All study visits will be held at the New York State Psychiatric Institute/Columbia University Medical Center at 1051 Riverside Drive in Manhattan
Procedures for inclusion:
1.    Screening by phone.
2.    If potentially eligible, a psychiatric evaluation, urine test, and clinical assessments to confirm eligibility (time estimate of two hours).
3.    If eligible, research treatment over a period of 12 weeks.

Compensation: Participants will be compensated up to $300 for completing all study procedures during 8 visits to our clinic over a period of 12 weeks.

Exclusion Criteria: 

•    You are pregnant
•    You are currently on effective psychiatric medication

Contact: 
Rob Valdovinos, 646-774-8113, valdovi@nyspi.columbia.edu
Location: 
1051 Riverside Dr., New York, NY 10032
State: 
New York
Study End Date: 
Thu, 2015-12-31

Contact ADAA

8701 Georgia Ave., Suite #412
Silver Spring, MD 20910

240.485.1001

Contact ADAA

Request Publications

FacebookTwitterRSS

 

ADAA is a national nonprofit organization dedicated to the prevention, treatment, and cure of anxiety, OCD, PTSD, depression, and related disorders and to improving the lives of all people who suffer from them.

 

Privacy Policy 
© ADAA, 2010-2014